These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16416209)

  • 1. Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease.
    Riley TR; Kahn A
    Dig Dis Sci; 2006 Jan; 51(1):41-4. PubMed ID: 16416209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?
    Yatsuji S; Hashimoto E; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2005 Dec; 40(12):1130-8. PubMed ID: 16378177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.
    Vos B; Moreno C; Nagy N; Féry F; Cnop M; Vereerstraeten P; Devière J; Adler M
    Acta Gastroenterol Belg; 2011 Sep; 74(3):389-94. PubMed ID: 22103042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
    Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S
    Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
    Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
    Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases.
    Riley TR; Bruno MA
    J Clin Ultrasound; 2005 Dec; 33(9):439-41. PubMed ID: 16281268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.
    Goland S; Shimoni S; Zornitzki T; Knobler H; Azoulai O; Lutaty G; Melzer E; Orr A; Caspi A; Malnick S
    J Clin Gastroenterol; 2006; 40(10):949-55. PubMed ID: 17063117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics associated with hepatic steatosis on ultrasonography in patients with elevated alanine aminotransferase.
    Narciso-Schiavon JL; Schiavon Lde L; Carvalho-Filho RJ; Hayashida DY; Wang JH; Souza TS; Emori CT; Ferraz ML; Silva AE
    Sao Paulo Med J; 2010 Dec; 128(6):342-7. PubMed ID: 21308157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
    Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
    J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease.
    Akcam M; Boyaci A; Pirgon O; Koroglu M; Dundar BN
    Clin Imaging; 2013; 37(3):504-8. PubMed ID: 23601769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.
    Yang W; Huang H; Wang Y; Yu X; Yang Z
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):174-8. PubMed ID: 24025980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Anania C; Martino F; Cantisani V; Pascone R; Marcantonio A; Chiesa C
    Hepatology; 2010 Nov; 52(5):1643-51. PubMed ID: 20890890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.